膜杰作
Star Staining
1
Immuno-Oncology Summit 2019
会议时间：
2019年08月05日-2019年08月09日
主办单位：
Cambridge Healthtech Institute
| 会议资料包 |
主题介绍：
Over the past 7 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 5-day program and extensive networking opportunities that CHI's IO Summit provides.
After extensive research with industry insiders, we bring you a comprehensive program that covers the latest developments and opportunities in 2019:
After extensive research with industry insiders, we bring you a comprehensive program that covers the latest developments and opportunities in 2019:
- Expanded coverage of Emerging Immuno-Oncology Targets goes beyond one track and features dedicated sessions throughout the 5-day IO Summit, including immunomodulatory targets for combination therapy with checkpoint inhibitors, innate immunity targets, cytokine targets, small molecule targets, and neoantigen targets.
- Comprehensive coverage of Emerging Targets and Modalities for Combination Immunotherapy. In addition to a dedicated track, the 5-day IO Summit features sessions on combination strategies to increase response to checkpoint modulators, combinations with novel immunotherapy modalities or with other cancer therapies, using biomarkers to guide combination therapy, emerging targets for combinations with checkpoint inhibitors, targeting innate immunity in combination immunotherapy, using bispecific antibodies for dual targeting, and dedicated coverage of using oncolytic viruses and personalized vaccines in combination with other immunotherapies.
- Latest research on immunotherapy modalities will be presented in comprehensive tracks covering Bispecific Antibodies, Oncolytic Virus Immunotherapy, Adoptive Cell Therapy, and Personalized Cancer Vaccines.
- New track on Next-Generation Immunotherapies covers the latest approaches in immuno-oncology, including advances in protein engineering, small molecule and antibody-drug conjugate immunotherapies, and engineered cytokines
- The latest Immuno-Oncology predictive and translational tools and technologies will be reviewed in the Biomarkers and Preclinical IO tracks, including predictive biomarkers, tumor microenvironment characterization, understanding resistance mechanisms, as well as emerging cellular and mouse models for immunotherapy development.
- New track on Informatics for Cancer Immunotherapies addresses the use of artificial intelligence, machine learning, and analytics to understand cancer genomics, immunology and patient response leading to precise cancer therapies.
会议日程：
推荐会议更多
ACRO最新 & 热门产品
补充会议信息
赢取积分奖励
赢取积分奖励
申请免费参会名额
兑换成功！
免费名额将于3个工作日内发送至您的注册手机和邮箱，
请注意查收~
申请成功！
您已成功申请此次会议资料包，
我们将于2个工作日内将资料包发送至您的邮箱，请注意查收
申请会议资料包
转发分享下面链接后截图上传，即可或得对应会议资料。
